News & Updates
Showing Multidisciplinary articles
Showing
MAURIS interim safety and efficacy results in “real-world” ES-SCLC patients similar to IMpower133
Interim results of the Italian, multicentre, open-label, phase IIIb MAURIS trial in “real-world” patients with untreated extensive-stage small-cell lung cancer (ES-SCLC) show similar safety and efficacy to those achieved by atezolizumab plus carboplatin and etoposide in the pivotal, phase I/III IMpower133 trial.
MAURIS interim safety and efficacy results in “real-world” ES-SCLC patients similar to IMpower133
28 May 2024
Impaired thyroid hormone sensitivity ups MACE risk in angiography patients
Euthyroid patients undergoing coronary angiography who have impaired sensitivity to thyroid hormone are at increased risks of major adverse cardiovascular events (MACE) and cardiovascular death, a recent study has shown.
Impaired thyroid hormone sensitivity ups MACE risk in angiography patients
27 May 2024
Transurethral water vapour thermal therapy effective and safe in Chinese BPH patients
Transurethral water vapour thermal therapy (WVTT) delivered in an office-based setting under local anaesthesia alone is an effective and safe alternative for surgical treatment of benign prostatic hyperplasia (BPH) in Chinese patients, researchers from the Chinese University of Hong Kong (CUHK) have reported.